Off-label cases against the FDA move forward

Amarin begins legally promoting off-label uses of its prescription fish-oil drug, while Pacira sues the FDA over the label for its pain drug, Exparel.

from Most popular articles from Medical Marketing and Media http://ift.tt/1L4gEqZ